MMR Information Systems, Inc. Shareholder Update Regarding Clinical Trials Data for Cancer Vaccine

LOS ANGELES, CA--(Marketwire - March 2, 2010) -  MMR Information Systems (OTCBB: MMRF) (the "Company") disclosed today that it was recently contacted by Ronald Levy, MD, Chief of the Oncology Division at Stanford University School of Medicine and discoverer of Rituxan®, the first monoclonal antibody approved to treat cancer (http://med.stanford.edu/labs/ronald_levy). Dr. Levy requested certain data from Favrille's (the Company's pre-merger predecessor) vaccine trials for a project that theoretically could be used to predict the outcomes of patients vaccinated with idiotype vaccines. The Company has been advised that the project would seek to determine if it may be possible to predict which lymphoma patients vaccinated with a customized product made from their own tumor cells could conceivably mount a productive immune response against their own tumor. The Company has also been advised that results of such a project, if favorable, could have the potential to lead to a re-interpretation of the previous Favrille cancer vaccine trials.

The Company acquired these intellectual property assets and related technology through its reverse merger with Favrille, Inc., a biopharmaceutical company, in January 2009. Favrille was previously based in San Diego. The Company has had preliminary discussions with Dr. Levy and the Stanford University Office of Technology regarding these assets which may also be of value to other biopharmaceutical companies, academic institutions and other entities.

Because of its interest in maximizing shareholder value of all of its assets, the Company will engage consultants to respond to opportunities that could maximize the value of the Company's pre-merger Favrille assets on a worldwide basis, the outcomes of which may not be known for some time. These assets include, but are not limited to, data from the Company's pre-merger clinical vaccine trials, the Specifid vaccine, and the anti-CD20 antibodies.

The Company remains focused on its primary business, which is specifically the development and distribution of the MyMedicalRecords Personal Health Record, www.MyMedicalRecords.com, MMRPro at www.MyMedicalRecordsMD.com, and other related solutions in Health IT based on the Company's patented technologies. MMRPro is a professional document management solution that digitizes paper-based medical records for healthcare professionals while sharing them with patients in real time.

About MMR Information Systems, Inc.
MMR Information Systems, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, unions and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR clients have included AFL-CIO, Alexian Brothers Hospital Network, Coverdell, LegalZoom, The Latino Coalition, MedicAlert, NRA, XN Financial and others. MMR is also an integrated service provider on Google Health. To learn more about MMR Information Systems, Inc. visit www.mymedicalrecords.com.

Forward-Looking Statements
Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, statements regarding the Company's assets including but not limited to its primary Health IT businesses, data from Specifid vaccine and clinical trials, anti-CD20 antibody assets or the Company's ability to enter into a successful agreement with Stanford University Office of Technology or any interested party, the outcome of which may not be known for some time. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the development and approval of biotechnology product candidates and Health IT products and additional risks discussed in the Company's filings with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to the Company (or any person acting on the Company's behalf) are qualified by the cautionary statements in this notice. MMR Information Systems, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information:

CONTACT:

Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com

Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz